Figure 3.
Figure 3. Proposals for therapeutic options in MDS based on patient’s IPSS category, age, and performance status: NCCN MDS Panel Guidelines.51,52 Treatments are listed in order of preference. The term ‘rAML induction’ indicates use of chemotherapeutic induction regimens planned for ‘resistant-type AML.’. / Abbreviations: NCCN, National Comprehensive Cancer Network; BMT, bone marrow transplant. / Reprinted with permission from Gotlib J, Greenberg P. Myelodysplastic syndromes. In Henderson E, Lister TA, Greaves M, eds. Leukemia, 7th Edition. Elsevier Science: Philadelphia, PA; 2002:562.

Proposals for therapeutic options in MDS based on patient’s IPSS category, age, and performance status: NCCN MDS Panel Guidelines.51,52 Treatments are listed in order of preference. The term ‘rAML induction’ indicates use of chemotherapeutic induction regimens planned for ‘resistant-type AML.’

Abbreviations: NCCN, National Comprehensive Cancer Network; BMT, bone marrow transplant.

Reprinted with permission from Gotlib J, Greenberg P. Myelodysplastic syndromes. In Henderson E, Lister TA, Greaves M, eds. Leukemia, 7th Edition. Elsevier Science: Philadelphia, PA; 2002:562.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal